Despite the significant interaction between HEY1-NCOA2 and Runx2, CRISPR/Cas9-mediated homozygous deletion of Runx2 failed to show growth suppression of tumor cells in vitro (Figure 6A and Supplemental Figure 6, A and B). Here, RUNX2 is linked to neoplasm.